Article
The genomic signature of resistance to platinum-containing neoadjuvant therapy based on single-cell data
2023-03-24
Abstract excerpt
<h4>Background: </h4> Neoadjuvant chemotherapy (NACT) becomes the first-line option for advanced tumors, while patients who are not sensitive to it may not benefit. Therefore, it is important to screen patients suitable for NACT. <h4>Methods: </h4> Single-cell data of lung adenocarcinoma (LUAD) and esophageal squamous carcinoma (ESCC) before and after cisplatin-containing (CDDP) NACT and cisplatin IC50 data of tu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7bde1d02-f00f-5dbe-bb31-27ac937cef57
- DOI
- 10.21203/rs.3.rs-2686396/v1
